Form 4: CRDO director awarded 2,695 RSUs; post‑grant 6,045 held

Rhea-AI Filing Summary

Credo Technology Group Holding Ltd (CRDO) reported a director equity award on 11/13/2025. The filing shows 2,695 ordinary shares acquired at $0 from an RSU grant, bringing directly held shares to 6,045. The RSUs vest in equal one‑third installments on October 27, 2026, October 27, 2027, and October 27, 2028, contingent on continued service.

Insider Trade Summary

Net Buyer: 2,695 shares

Net Buy 1 txn

Insider Kelleher Brian

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	2,695	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 6,045 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units that will vest in substantially equal one third installments on each of October 27, 2026, October 27, 2027 and October 27, 2028, subject to the Reporting Person continuing as a service provider through each such date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 11/13/2025 - 03:26 PM Learn about SEC filing dates

FAQ

What did Credo (CRDO) report in this Form 4?

A director received an award of 2,695 RSUs that reflect as ordinary shares acquired at $0, with total directly held shares now 6,045.

How many Credo (CRDO) shares does the reporting person hold after the transaction?

The reporting person beneficially owns 6,045 shares directly after the reported transaction.

What was the transaction date for the Credo (CRDO) Form 4?

The transaction date was 11/13/2025.

What is the vesting schedule for the 2,695 RSUs at Credo (CRDO)?

The RSUs vest in substantially equal one‑third installments on October 27, 2026, October 27, 2027, and October 27, 2028, subject to continued service.

What is the ownership form reported for the Credo (CRDO) shares?

The ownership form is reported as Direct (D).

What was the reported price for the acquired Credo (CRDO) shares?

The filing reports a price of $0 for the 2,695 shares associated with the RSU grant.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kelleher Brian

(Last) (First) (Middle)

110 RIO ROBLES

(Street)

SAN JOSE CA 95134

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Credo Technology Group Holding Ltd [ CRDO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	11/13/2025		A		2,695(1)	A	$0	6,045	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units that will vest in substantially equal one third installments on each of October 27, 2026, October 27, 2027 and October 27, 2028, subject to the Reporting Person continuing as a service provider through each such date.

Remarks:

	/s/ James Laufman, attorney-in-fact	11/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.